Chemoinformaics analysis of 5,7-Dihydroxy-2-(hydroxymethyl)-4H-1-benzopyran-4-one
Molecular Weight | 208.169 | nRot | 1 |
Heavy Atom Molecular Weight | 200.105 | nRig | 12 |
Exact Molecular Weight | 208.037 | nRing | 2 |
Solubility: LogS | -2.715 | nHRing | 1 |
Solubility: LogP | 0.395 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
No. of Oxygen atom | 5 | No. of Arom Bond | 11 |
nHA | 5 | APOL | 26.0443 |
nHD | 3 | BPOL | 10.6297 |
QED | 0.641 |
Synth | 2.516 |
Natural Product Likeliness | 1.881 |
NR-PPAR-gamma | 0.38 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.001 |
Pgp-sub | 0.931 |
HIA | 0.107 |
CACO-2 | -4.87 |
MDCK | 0.00000776 |
BBB | 0.013 |
PPB | 0.667271 |
VDSS | 0.817 |
FU | 0.453834 |
CYP1A2-inh | 0.929 |
CYP1A2-sub | 0.414 |
CYP2c19-inh | 0.043 |
CYP2c19-sub | 0.06 |
CYP2c9-inh | 0.073 |
CYP2c9-sub | 0.854 |
CYP2d6-inh | 0.105 |
CYP2d6-sub | 0.434 |
CYP3a4-inh | 0.113 |
CYP3a4-sub | 0.111 |
CL | 9.509 |
T12 | 0.915 |
hERG | 0.032 |
Ames | 0.5 |
ROA | 0.029 |
SkinSen | 0.868 |
Carcinogencity | 0.036 |
EI | 0.914 |
Respiratory | 0.287 |
NR-Aromatase | 0.264 |
Antiviral | No |
Prediction | 0.811635 |